Focussing on volume led growth, not price led growth: Lal Path Labs

"We look forward to delivering normal rate of growth on the non Covid side, as it is the focus of what we would like to do"-- said Bharath Uppiliappan, CEO, Dr Lal Path Labs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rOp7s9
via IFTTT